{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:03:41Z","timestamp":1790870621130,"version":"4.1.0"},"reference-count":17,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":663,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p>Peripheral blood from patients with multiple myeloma (MM) contains a small number of plasma cells related to the bone marrow tumour cells by their cytoplasmic immunoglobulin (Ig), their cell membrane antigen expression and\/or their gene rearrangements, but hitherto the monoclonal Ig (M\u2010Ig) production by circulating cells has not been reported. Using a two\u2010colour ELISPOT assay, Ig\u2010secreting cells (Ig\u2010SCs) were detected in the blood of 28 MM and five Waldenstrom's macroglobulinaemia (WM) patients. The number of cells that spontaneously produced an Ig isotype similar to that of the M\u2010Ig in serum was greater than that of the other Ig\u2010SCs. MM patients presented an excess of circulating heavy\u2010chain (\u03b1 or \u03b3) Ig\u2010SCs (0.38% of the PBMC) with \u03ba or \u03bb light chains (0.48%) compared with the number of cells secreting the other heavy\u2010 (0.02%) and light\u2010chain isotypes (0.03%). WM patients also presented high numbers of cells secreting the \u03bc\u2010heavy\u2010chain isotype (0.66%). The Ig synthesized <jats:italic>in vitro<\/jats:italic> was characterized as monoclonal, and the M\u2010Ig secretory capacity of the peripheral blood cells was similar to that observed for Ig\u2010SCs from polyclonal activated B cells <jats:italic>in vivo<\/jats:italic>. The number of these monoclonal cells was significantly increased in patients in an advanced stage of MM (I\/II vs. III, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) and correlated with the serum beta\u20102 microglobulin concentration (<jats:italic>r<\/jats:italic>\u2003=\u20030.69; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0003). The number of M\u2010Ig\u2010SCs in MM patients could be a useful marker for evaluating the progression of multiple myeloma.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01899.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:21:59Z","timestamp":1047363719000},"page":"549-558","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Spontaneous monoclonal immunoglobulin\u2010secreting peripheral blood mononuclear cells as a marker of disease severity in multiple myeloma"],"prefix":"10.1111","volume":"108","author":[{"given":"Franck","family":"Cordoba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lavabre\u2010Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Lynn","family":"Salhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie France","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Gerfaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Francois","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,4,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.4049\/jimmunol.143.7.2146","article-title":"HIV\u20101 specific B cell activation: a major constituent of spontaneous B cell activation during HIV\u20101 infection","volume":"143","author":"Amadori A.","year":"1989","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199706053362307"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood.V63.2.468.468","article-title":"Beta\u20102 microglobulin in myeloma, optimal use for staging, prognosis and treatment. A prospective study of 160 patients","volume":"63","author":"Bataille R.","year":"1984","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V80.3.733.733","article-title":"C\u2010reactive protein and b\u20102 microglobulin produce a simple and powerful myeloma staging system","volume":"80","author":"Bataille R.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V87.5.1972.1972","article-title":"Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells","volume":"87","author":"Bengzeng J.C.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood.V80.7.1818.1818","article-title":"Detection and quantification of malignant cells in the peripheral blood of multiple myeloma patients","volume":"80","author":"Billadeau D.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V88.1.289.289","article-title":"Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma and active myeloma","volume":"88","author":"Billadeau D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_9_2","first-page":"1437","article-title":"Impairment of B\u2010lymphocyte differentiation induced by triggering of the B\u2010cell antigen receptor and CD40 in advanced HIV\u20101 disease","volume":"12","author":"Conge A.M.","year":"1998","journal-title":"Acquired Immunodeficiency Disease Syndrome"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(88)90306-7"},{"key":"e_1_2_6_11_2","first-page":"707","article-title":"Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma","volume":"15","author":"Dreyfus F.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_12_2","unstructured":"Durie B.G.M.&Salmon S.S.(1985)Staging Kinetics and Flow Cytometry of Multiple Myeloma Vol. 2.Neoplastic Diseases of the Blood. Churchill Livingston New York."},{"key":"e_1_2_6_13_2","first-page":"135","article-title":"Immunoglobulin synthesis and tumor kinetics of multiple myeloma","volume":"10","author":"Salmon S.E.","year":"1973","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V92.8.2844","article-title":"A high frequency of circulating B cells share clonotypic Ig heavy\u2010chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single\u2010cell and in situ reverse transcriptase polymerase chain reaction","volume":"92","author":"Szczepek A.J.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/iai.50.1.310-316.1985","article-title":"Brucella fractions behave as nonspecific mitogens and polyclonal B\u2010cell activators for human lymphocytes","volume":"50","author":"Vendrell J.P.","year":"1985","journal-title":"Infection and Immunity"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1991.tb05614.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0320(19960615)26:2<113::aid-cyto3>3.0.co;2-h"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.5.1780.1780"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01899.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01899.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01899.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T16:44:11Z","timestamp":1698597851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01899.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01899.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01899.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"2002-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}